Bloomington, Ind. – Cook is pleased with bipartisan efforts by the U.S. House of Representatives to help bring new life-saving medical devices to patients by passing H.R. 184, the Protect Medical Innovation Act. This legislation would permanently repeal the medical device tax.
“Cook Medical thanks the 283 legislators who recognize that the medical device excise tax is a tax on patient care and raises healthcare costs. Their vote in favor of repealing this tax will help spur medical innovation in the U.S. that, in turn, helps patients around the world,” said Steve Ferguson, chairman of Cook Group, Cook Medical’s parent company. “We urge the Senate to take immediate action to help patients who look to our industry to continue researching and developing innovative therapies for those who need it most.”
“In a competitive global market, a full repeal of the tax would provide security for companies like Cook to continue investment and growth in the U.S. providing long-term benefits for jobs, communities and ultimately patients needing the best health care technologies possible.”
Medical technology directly and indirectly employs more than two million people across the U.S. Repealing this tax is important to the individuals who produce and develop life-saving technologies like the approximately 7,000 Cook Medical employees in the U.S.
About Cook Medical
Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities. Find out more at www.cookmedical.com, and for the latest news, follow us on Twitter, Facebook and LinkedIn.